• The research at the Institute of Radiation Biology (ISB) focuses on the health challenges posed by the chronic diseases that develop in long-term survivors of cancer radiotherapy. Our goal is to minimise the pathophysiology, in particular in tissues at the periphery of the radiation field receiving low radiation doses. The research groups examine the physiological effects of low doses of radiation in the brain, heart and lung tissue, in stem cells and in endothelial cells. We are developing pharmacological strategies to lower radiation doses and to ameliorate damage, and we investigate the influence of genetic and epigenetic regulation in determining the response of individual patients. The ISB is a part of the Department of Radiation Sciences (DRS).

We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Only cookies permitted that are required for the basic functionality of our websites.
Permit cookies that help us to analyse the page views and user behavior on our websites. We only use this information for improving our services.
Permit embedded content and cookies from third party providers. This setting enables the full use of our web services (e.g. displaying videos).
Please find more information in our privacy statement.

There you may also change your settings later.